Skip to content
Clinical Trials – home
Azienda USL IRCCS Di Reggio Emilia
Sponsor

Azienda USL IRCCS Di Reggio Emilia

Italy Viale Risorgimento 80, 42123 Reggio Emilia, Italy

About the sponsor

The clinical research activity is centered on metastatic colorectal cancer, with attention to patients requiring first-line treatment for advanced disease. The sponsor’s funded trial examines treatment choices in this setting and reflects a focused interest in disease management for mCRC.

  • Metastatic colorectal cancer
  • Advanced gastrointestinal oncology
  • First-line systemic therapy

Clinical interest extends to therapeutic decision-making in patients with newly diagnosed metastatic disease, particularly where treatment selection may influence disease control and progression outcomes.

About Specializations

Azienda USL IRCCS Di Reggio Emilia runs clinical trials in conditions such as Colorectal cancer metastatic, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Study Comparing FOLFIRI with Cetuximab or Bevacizumab for First-Line Treatment in Patients with Metastatic Colorectal Cancer and Specific Genetic Profiles

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Azienda USL IRCCS Di Reggio Emilia

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.